Clinical Trial Update: Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study [Phase 2]

View source ↗

Summary

A Phase II clinical trial update on maintenance therapy for HER2-positive unresectable locally recurrent or metastatic breast cancer; the study is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: HER2-positive Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING